Oto Revenue and Competitors
Estimated Revenue & Valuation
- Oto's estimated annual revenue is currently $5.3M per year.
- Oto's estimated revenue per employee is $330,750
Employee Data
- Oto has 16 Employees.
- Oto grew their employee count by -20% last year.
Oto Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $25.9M | 77 | -3% | N/A | N/A |
#2 | $34.6M | 109 | 3% | N/A | N/A |
#3 | $55.2M | 171 | 5% | N/A | N/A |
#4 | N/A | 0 | N/A | N/A | N/A |
#5 | $23M | 85 | -19% | £8.2M | N/A |
#6 | $7.8M | 27 | -10% | N/A | N/A |
#7 | $20.5M | 60 | -5% | N/A | N/A |
#8 | $138M | 369 | 9% | N/A | N/A |
#9 | $143.1M | 390 | 5% | N/A | N/A |
#10 | $108.7M | 301 | 6% | N/A | N/A |
What Is Oto?
Oto builds digital therapeutics for tinnitus. There are 390 million people with intrusive tinnitus around the world. Our mission to help them, by providing science-based therapy, that is accessible to all.
keywords:N/AN/A
Total Funding
16
Number of Employees
$5.3M
Revenue (est)
-20%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Oto's People
Name | Title | Email/Phone |
---|---|---|
1 | Hearing Therapist | Reveal Email/Phone |
2 | Product Manager | Reveal Email/Phone |
3 | Co-Founder | Reveal Email/Phone |
4 | Founder associate | Reveal Email/Phone |
Oto News
Clinical benefit again observed for OTO-413 versus placebo for ... the Phase 2a clinical trial of OTO-413 in subjects with hearing loss.
He will be a tarting linebacker for the Crimson Tide to open up the 2022 season. Henry To'oto'o's Photo Gallery. Syndication: Tuscaloosa News.
Clinical benefit again observed for OTO-413 versus placebo for ... the Phase 2a clinical trial of OTO-413 in subjects with hearing loss.
He will be a tarting linebacker for the Crimson Tide to open up the 2022 season. Henry To'oto'o's Photo Gallery. Syndication: Tuscaloosa News.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.7M | 16 | -11% | N/A |
#2 | $21M | 16 | -81% | N/A |
#3 | $2.1M | 16 | -6% | N/A |
#4 | $1.4M | 16 | N/A | N/A |
#5 | $1.4M | 16 | N/A | N/A |